Infobricks LogoInfobricks Text Image
Hamburger Icon

Intelligent Automation for Faster, Smarter Clinical Trials.

Transform clinical trial document creation with our AI-powered agent that intelligently drafts Informed Consent Forms and regulatory documents. Streamline your study startup process with template-driven automation, reducing manual workload while ensuring compliance and patient comprehension.

Sarah Johnson

Sarah Johnson

CTO at TechCorp

Infobricks has transformed how we leverage our enterprise data with AI. The implementation was smooth, and the ROI has been remarkable within just the first quarter.

Exceeding our expectations

TRUSTED BY INNOVATORS

Sarah Johnson
Sarah
Michael Chen
Michael
Emma Wilson
Emma
Infobricks AI Platform
Vector Graphic
Vector Graphic

Accelerate Trials

Reduce ICF drafting time

Clear Consent

Improve patient comprehension

Boost Compliance

Meet regulatory standards

Empower Teams

Focus on strategic tasks

AI-Powered Context-Aware Drafting

Intelligent document creation using Large Language Models, Agentic AI, and RAG for superior accuracy.

Our AI agent uses RAG to ground itself in study-specific documents, intelligently extracting and synthesizing information while ensuring all regulatory-mandated elements are included and optimizing for patient comprehension.

No-Code Document Automation

Template-driven automation that adapts to your existing workflows without coding requirements.

Takes your existing document templates (ICF templates) and processes relevant source documents (protocols, investigator brochures) to automatically generate accurate, compliant, and easy-to-understand clinical trial documents.

Centralized Review & Compliance

Human-in-the-Loop approach ensuring regulatory compliance with streamlined review processes.

Generates high-quality draft ICFs ready for human review and finalization. Our approach emphasizes that AI assists while humans validate, ensuring regulatory compliance and reducing errors while empowering your team.

Why
infobricks.ai

Solving the clinical trial documentation bottleneck

Clinical Trials are Drowning in Paperwork

Manual document creation like Informed Consent Forms is a major bottleneck in study startup. The manual creation process for ICFs is time-consuming, requiring careful inclusion of all regulatory-mandated elements.

Time-Consuming & Error-Prone Process

Significant manual workload for pharma, CROs, and research institutions. Manual drafting leads to errors, inconsistencies, and compliance risks while creating lengthy, complex documents filled with technical jargon.

Delays Life-Saving Treatments

Poor patient comprehension impacts truly informed consent. This bottleneck delays trial initiation, increases costs, and ultimately slows down the delivery of novel drugs to patients who need them most.

What is infobricks.ai

Your AI-powered agent for intelligent document drafting. An AI-centric application that automates the creation of clinical trial documents, starting with Informed Consent Forms.
What is Infobricks diagram
Template-Driven Document Drafting

Takes your existing document templates (e.g., ICF templates) and processes relevant source documents like study protocols and investigator brochures to intelligently draft accurate, compliant documents.

AI-Powered Agentic Application

Our AI-centric document drafter uses Large Language Models (LLMs), Agentic AI, and Retrieval Augmented Generation (RAG) for superior accuracy and context-awareness in clinical document creation.

Automated ICF Generation

Initial focus on automated generation of Informed Consent Forms (ICFs) for clinical trials, creating easy-to-understand documents that meet regulatory requirements while improving patient comprehension.

POWERFUL CAPABILITIES

Features & Benefits

infobricks.ai delivers faster trials, clearer consent, and reduced burden through intelligent document automation for clinical research.

Accelerate Trial Timelines

Drastically reduce time spent on drafting ICFs and study documents. Enable up to 50% cost reductions in clinical development through streamlined processes.

Improve Patient Comprehension

Generate ICFs that are clearer, more understandable, and actionable for patients, supporting true informed consent and engagement.

Enhance Quality & Consistency

Ensure accuracy and uniformity across documents, minimizing errors and regulatory queries through AI-powered drafting.

Reduce Costs

Lower person-hours and resources dedicated to manual document preparation, freeing up budget for critical trial activities.

Boost Compliance

Our AI incorporates regulatory requirements, helping ensure documents meet standards and reduce compliance risks.

Empower Your Team

Free up skilled clinical operations staff and medical writers to focus on higher-value strategic tasks and trial optimization.

``
SIMPLE PROCESS

How It Works

Intelligent automation with human oversight for clinical trial document creation

Input & Contextual Understanding

User uploads study-specific templates and source documents like protocols and investigator brochures.

Our AI agent uses RAG to ground itself in these specific documents, ensuring relevance and accuracy. The system securely processes your existing templates and study documentation to understand the unique context and requirements.

AI-Powered Drafting
Review & Refinement
OUR VISION

Automating the Clinical Trial Document Lifecycle

Beyond ICFs: Our roadmap to becoming the leading AI platform for all essential clinical trial documents

Informed Consent Forms

Our current focus: Perfecting ICF automation for clinical trials with AI-powered document generation.

Key Benefits:
  • Automated ICF generation from templates
  • Regulatory compliance built-in
  • Improved patient comprehension
Success Story

Currently perfecting ICF automation to reduce manual document creation time by up to 80% while ensuring regulatory compliance and patient understanding.

Informed Consent Forms Illustration

HAVE QUESTIONS?

Frequently Asked Questions

Find answers to common questions about infobricks.ai and our clinical trial document automation solutions

infobricks.ai is your AI-powered agent for intelligent document drafting. We have developed an AI-centric document drafter agentic application that automates the creation of clinical trial documents, starting with Informed Consent Forms (ICFs).

Our system works in three steps: 1) Input & Contextual Understanding - upload study-specific templates and source documents; 2) AI-Powered Drafting - our agentic system orchestrates intelligent document creation with regulatory compliance; 3) Review & Refinement - generates high-quality drafts ready for human review with our Human-in-the-Loop approach.

Currently, we focus on perfecting ICF automation. Our future roadmap includes Clinical Study Protocols (CSPs), Investigator's Brochures (IBs), Case Report Forms (CRFs), Clinical Study Reports (CSRs), and regulatory submission packages to automate the entire clinical trial document lifecycle.

We serve pharmaceutical companies (small, medium, large), biotechnology companies, Contract Research Organizations (CROs), and academic research institutions. Key stakeholders include Clinical Operations Personnel, Medical Writers, and Regulatory Affairs Professionals seeking to optimize R&D and accelerate drug development.

Our platform accelerates trial timelines, improves patient comprehension with clearer consent forms, enhances quality and consistency, reduces costs by lowering manual document preparation time, boosts regulatory compliance, and empowers your team to focus on higher-value strategic tasks.

Our AI uses Retrieval Augmented Generation (RAG) to ground itself in study-specific documents, ensuring relevance and accuracy. The system incorporates regulatory requirements, uses template-driven approaches that adapt to your workflows, and minimizes hallucinations through source document grounding for factual, study-specific outputs.

Still have questions?

Stay Updated with infobricks.ai

Subscribe for the latest updates on clinical trial document automation, regulatory insights, and AI innovations in pharmaceutical research.